The Pfizer-BioNTech COVID-19 vaccine provided children and teens in England with only about 14 to 15 weeks of protection against testing positive for the virus, according to aΒ preprint studyΒ of over 1.7 million children ages 5 to 15 in the English National Healthcare System (NHS).
Researchers investigating the safety and effectiveness ofΒ Pfizerβs vaccineΒ in fully vaccinated, partially vaccinated, and unvaccinated children and teens, also found cases ofΒ myocarditisΒ and pericarditis only in vaccinated children.
βThis study clearly shows that Pfizerβs COVID vaccine provides almost no benefit to children and adolescents, but does increase their risk of myocarditis and pericarditis,β said Brian Hooker, Ph.D., chief scientific officer of Childrenβs Health Defense. βIt begs the question: Why does the CDC continue to recommend these unlicensed shots for kids? Where is the data they use to support their statement that the benefits of these vaccines outweigh the risks?β
The study found that vaccinated children required slightly fewer emergency room visits and hospital stays, but that those outcomes were extremely rare in children and teens across all groups.
In total, 410,463 teenagers who received one dose of the vaccine were matched to unvaccinated controls, and 220,929 adolescents who received two shots were matched to single-vaccinated controls.
Of the 1,262,784 children in the adolescent part of the study β vaccinated and unvaccinated β there were only 72 emergency room visits, 90 COVID-19 hospitalizations β three of which were critical care for unvaccinated children β and no deaths.
There were nine cases of pericarditis and three cases of myocarditis, all in the vaccinated group.
